Transplant recipient's knowledge of posttransplant malignancy risk: Implications for educational programs

Transplantation

Volumn 85, Issue 7, 2008, Pages 928-933

  Kauffman, H Myron ^a   Woodle, E Steve ^b   Cole, Edward H ^c   Paykin, Catherine ^d  

^a UNITED NETWORK FOR ORGAN SHARING   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d NATIONAL KIDNEY FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; EDUCATION PROGRAM; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; KIDNEY TRANSPLANTATION; KNOWLEDGE; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT EDUCATION; PRIORITY JOURNAL; RISK FACTOR;

HEALTH SURVEYS; HUMANS; KIDNEY TRANSPLANTATION; KNOWLEDGE; NEOPLASMS; PATIENT EDUCATION AS TOPIC; PERCEPTION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 42149178392     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31816a105b     Document Type: Article

References (22)

1. Kauffman HM, McBride MA, Cherikh WS, et al. Transplant tumor registry: Donor related malignancies. Transplantation 2002; 74: 358.
2. Kauffman HM, McBride MA, Cherikh WS, et al. Transplant tumor registry: Donors with central nervous system tumors. Transplantation 2002; 73: 579.
3. Buell JF, Gross T, Alloway RR, et al. Central nervous system tumors in donors: Misdiagnosis carries a high morbidity and mortality. Transplant Proc 2005; 37: 583.
4. Kauffman HM, McBride MA, Delmonico FL. First report of the United Network for Organ Sharing Transplant Tumor Registry: Donors with a history of cancer. Transplantation 2000; 70: 1747.
5. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV. Long-term management of the transplant recipient. Nephrol Dial Transplant 2002; 17(suppl 4): 1.
6. Munoz P. Management of urinary tract infections and lymphocele in renal transplant recipients. Clin Infect Dis 2001; 33(suppl 1): S53.
7. Chapman JR, Sheil AG, Disney AP. Recurrence of cancer after renal transplantation. Transplantation Proc 2001; 33: 1830.
8. ANZDATA Registry Report 2004. In: Excell L, McDonald S, eds. Australia and New Zealand Dialysis and Transplant Registry. Adelaide, South Australia, ANZDATA, 2004.
9. Kauffman HM, Cherikh WS, McBride MA, et al. Post-transplant de novo malignancies in renal transplant recipients: The past and present. Transpl Int 2006; 19: 607.
10. Zmonnnarski SC, Boratnska M, Rbczynski J K, et al. Regression of Kaposi sarcoma in renal transplant recipients after conversion to sirolimus treatment. Transplant Proc 2005; 37: 964.
11. Kahan BD, Yakupoglu YK, Schoenbert L, et al. Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients. Transplantation 2005; 80: 749.
12. El-Agroudy AE, El-Bz MA, Ismail AM, et al. Clinical features and course of Kaposi sarcoma in Egyptian kidney transplant recipients Am J Transplant. 2003; 37: 964.
13. Cherikh WS, Kauffman HM, Shames BD, et al. Association of different immunosuppressive regimens with posttransplant de novo malignancies in liver recipients. Am J. Transplant 2005; 5(suppl 11): 392.
14. Stallone G, Schena A, Infante, B, et al. Sirolimus for Kaposi sarcoma in renal-transplant recipients. N Engl J Med 2005; 352: 1317.
15. Gallo P, Agozzino L, Angelini A, et al. Causes of late failure after heart transplantation:Aten year survey. J Heart Lung Transplant 1997; 16: 1113.
16. Jain AB, Yee LD, Nalesnik MA, et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998; 66: 1193.
17. Del Rosso JQ. Pharmacotherapy update: Non-melanoma skin cancer and transplant patients. Are they being educated about their risks? Skin Aging 2006;14: 62.
18. Cowen EW, Billingsley EM. Awareness of skin cancer by kidney transplant patients. J Am Acad Dermatol 1999; 40: 697.
19. Vajdick CM, McDonald SP, McCredie MRE, et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823.
20. Chapman JR, Webster AC. Cancer after renal transplantation. Am J Transplantation 2004; 4: 841.
21. Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the US. Am J Transplant 2004; 4: 905.
22. Villeneuve PJ, Schaubel DE, Fenton SS, et al. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant 2005; 7: 941.